What are the treatment options for eccrine hydrocystomas or syringomas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Eccrine Hydrocystomas and Syringomas

For eccrine hydrocystomas, botulinum toxin A (BTX-A) intradermal injection is the preferred first-line treatment due to its ease of application, absence of scarring risk, and excellent cosmetic outcomes, while syringomas are best treated with CO2 laser ablation using high-energy settings (5 watts, 0.2 second scan time) for complete elimination without scarring. 1, 2

Treatment Approach for Eccrine Hydrocystomas

First-Line Treatment: Botulinum Toxin A

  • BTX-A should be injected superficially into the epidermis at the sites of multiple eccrine hidrocystomas 2
  • The mechanism works by blocking cholinergic terminals of the parasympathetic system that governs sweat gland secretion 2
  • Key advantages include ease of application, no scarring risk, and good postoperative course 2
  • Periodic doses are required for maintenance as the effect is temporary 2

Alternative Treatment Options

  • Erbium-YAG laser followed by oral isotretinoin can be considered for difficult cases with multiple lesions 3
  • For lesions <1 cm: electrodesiccation is effective with no visible scarring at 1-year follow-up 4
  • For lesions >1 cm: surgical excision is recommended, though localized scars may occur 4

Treatment Approach for Syringomas

First-Line Treatment: CO2 Laser Ablation

  • Use high-energy scanned CO2 laser with specific settings: 5 watts power, 0.2 second scan time, 3mm spot size 1
  • Perform two passes initially; some lesions may require up to four passes 1
  • For extensive periorbital involvement, treat the entire lower periorbital area 1
  • This approach achieves complete elimination with no recurrence at 1-24 months follow-up and no scarring 1

Alternative Treatment: Intralesional Insulated Needles

  • Intralesional insulated needles provide selective destruction of dermal lesions while preserving the epidermis 5
  • The needles are insulated at the point of epidermal contact, preventing epidermal damage 5
  • This technique avoids hyperpigmentation and scarring that occur with conventional therapies 5

Treatments to Avoid

  • Conventional therapies including surgical excision, electrodesiccation, chemical peeling, topical atropine/tretinoin, and cryosurgery frequently cause cosmetic defects such as hyperpigmentation or scarring due to epidermal damage 5

Common Pitfalls and Caveats

For Eccrine Hydrocystomas

  • Do not attempt surgical excision for multiple lesions - the number and facial location make this problematic 2
  • Recognize that these lesions have a chronic course with seasonal variability 2
  • Patients often confuse these lesions with comedones, leading to delayed diagnosis 2

For Syringomas

  • Prolonged erythema is the most common side effect of CO2 laser treatment but resolves without intervention 1
  • Approximately 40% of patients (4 out of 10) may require repeat spot treatments for complete clearance 1
  • Avoid under-treatment: ensure adequate depth of ablation to prevent recurrence 1

Treatment Selection Algorithm

For eccrine hydrocystomas:

  1. Multiple facial lesions → BTX-A intradermal injection 2
  2. Refractory cases → Erbium-YAG laser + oral isotretinoin 3
  3. Lesions <1 cm → Electrodesiccation 4
  4. Lesions >1 cm → Surgical excision 4

For syringomas:

  1. Periorbital or facial lesions → High-energy CO2 laser ablation 1
  2. Desire for minimal epidermal damage → Intralesional insulated needles 5
  3. Repeat treatment at 1-2 months if incomplete clearance 1

References

Research

Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1999

Research

Multiple eccrine hidrocystomas: a new therapeutic option with botulinum toxin.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003

Research

Treatment of multiple eccrine hidrocystoma with oral isotretinoin following erbium-yttrium aluminum garnet laser.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2019

Research

The efficacy of electrosurgery and excision in treating patients with multiple apocrine hidrocystomas.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.